Cargando…

BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer

BRG1, a core component of the SWI/SNF chromatin-remodeling complex, has been implicated in cancer development; however, the biological significance of BRG1 in breast cancer remains unknown. We explored the role of BRG1 in human breast cancer pathogenesis. Using tissue microarray and immunohistochemi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Jin, Mei, Pengjin, Zhang, Cuipeng, Chen, Feifei, Li, Chen, Pan, Zhenqiang, Liu, Hui, Zheng, Junnian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606107/ https://www.ncbi.nlm.nih.gov/pubmed/23533649 http://dx.doi.org/10.1371/journal.pone.0059772

Ejemplares similares

RUNX3 Suppresses Migration, Invasion and Angiogenesis of Human Renal Cell Carcinoma
por: Chen, Feifei, et al.
Publicado: (2013)

BRG1 is a prognostic indicator and a potential therapeutic target for prostate cancer
por: Muthuswami, Rohini, et al.
Publicado: (2019)

BRG1 and NPM-ALK Are Co-Regulated in Anaplastic Large-Cell Lymphoma; BRG1 Is a Potential Therapeutic Target in ALCL
por: Garland, Gavin D., et al.
Publicado: (2021)

BRMS1 Suppresses Glioma Progression by Regulating Invasion, Migration and Adhesion of Glioma Cells
por: Mei, Pengjin, et al.
Publicado: (2014)

The role of chromatin remodeler SMARCA4/BRG1 in brain cancers: a potential therapeutic target
por: Navickas, Sophie M., et al.
Publicado: (2023)

Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer
por: Grönberg, Malin, et al.
Publicado: (2017)

Oncogene-dependent function of BRG1 in hepatocarcinogenesis
por: Wang, Pan, et al.
Publicado: (2020)

HCRP-1 regulates EGFR–AKT–BIM-mediated anoikis resistance and serves as a prognostic marker in human colon cancer
por: Chen, Feifei, et al.
Publicado: (2018)

The BRG1 transcriptional coregulator
por: Trotter, Kevin W., et al.
Publicado: (2008)

SMARCD3 is a potential prognostic marker and therapeutic target in CAFs
por: Jiang, Ming, et al.
Publicado: (2020)

BRG1: Promoter or Suppressor of Cancer? The Outcome of BRG1’s Interaction with Specific Cellular Pathways
por: Shaykevich, Aaron, et al.
Publicado: (2023)

Targeting the chromatin remodeling enzyme BRG1 increases the efficacy of chemotherapy drugs in breast cancer cells
por: Wu, Qiong, et al.
Publicado: (2016)

Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis
por: Zhang, Jing, et al.
Publicado: (2021)

PinX1 inhibits the invasion and metastasis of human breast cancer via suppressing NF-κB/MMP-9 signaling pathway
por: Shi, Meilin, et al.
Publicado: (2015)

Mechanism of BRG1 silencing in primary cancers
por: Marquez, Stefanie B., et al.
Publicado: (2016)

The Role of BRG1 in Antioxidant and Redox Signaling
por: You, Shilong, et al.
Publicado: (2020)

On the Interaction Between SMARCAL1 and BRG1
por: Bisht, Deepa, et al.
Publicado: (2022)

RUNX3 regulates renal cell carcinoma metastasis via targeting miR-6780a-5p/E-cadherin/EMT signaling axis
por: Chen, Feifei, et al.
Publicado: (2017)

Cyclin genes as potential novel prognostic biomarkers and therapeutic targets in breast cancer
por: Liu, Nian-Qiu, et al.
Publicado: (2022)

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
por: Zhang, Hao, et al.
Publicado: (2020)

Galectins as New Prognostic Markers and Potential Therapeutic Targets for Advanced Prostate Cancers
por: Laderach, Diego J., et al.
Publicado: (2013)

DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer
por: Song, L. J., et al.
Publicado: (2016)

Vitamin D as a Potential Therapeutic Target and Prognostic Marker for Colorectal Cancer
por: Bintintan, Vasile V.
Publicado: (2018)

BRG1 and BRM loss selectively impacts RB and P53, respectively: BRG1 and BRM have differential functions in vivo
por: Marquez-Vilendrer, Stefanie B., et al.
Publicado: (2016)

HCRP-1 regulates cell migration and invasion via EGFR-ERK mediated up-regulation of MMP-2 with prognostic significance in human renal cell carcinoma
por: Chen, Feifei, et al.
Publicado: (2015)

Corrigendum: HCRP-1 regulates cell migration and invasion via EGFR-ERK mediated up-regulation of MMP-2 with prognostic significance in human renal cell carcinoma
por: Chen, Feifei, et al.
Publicado: (2016)

BRG1 targeting STAT3/VEGFC signaling regulates lymphangiogenesis in colorectal cancer
por: Zhu, Xu, et al.
Publicado: (2016)

Targetable Brg1‐CXCL14 axis contributes to alcoholic liver injury by driving neutrophil trafficking
por: Li, Nan, et al.
Publicado: (2023)

BRG1 promotes hepatocarcinogenesis by regulating proliferation and invasiveness
por: Kaufmann, Benedikt, et al.
Publicado: (2017)

BRG1 Promotes chromatin remodeling around DNA damage sites
por: Qi, Wenjing, et al.
Publicado: (2018)

Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
por: Zhang, Hao, et al.
Publicado: (2014)

Insights into Orphan Nuclear Receptors as Prognostic Markers and Novel Therapeutic Targets for Breast Cancer
por: Aesoy, Reidun, et al.
Publicado: (2015)

ING4 suppresses tumor angiogenesis and functions as a prognostic marker in human colorectal cancer
por: Chen, Yansu, et al.
Publicado: (2016)

BRG1 Activates Proliferation and Transcription of Cell Cycle-Dependent Genes in Breast Cancer Cells
por: Sobczak, Maciej, et al.
Publicado: (2020)

Exportin-T: A Novel Prognostic Predictor and Potential Therapeutic Target for Neuroblastoma
por: Pan, Li-Jia, et al.
Publicado: (2021)

SMC4, a novel tumor prognostic marker and potential tumor therapeutic target
por: Zhao, Zonglei, et al.
Publicado: (2023)

C,C- and C,N-Chelated Organocopper Compounds
por: Liu, Liang, et al.
Publicado: (2021)

SGEF is a potential prognostic and therapeutic target for lung adenocarcinoma
por: Chen, Qian, et al.
Publicado: (2018)

RUNX2 interacts with BRG1 to target CD44 for promoting invasion and migration of colorectal cancer cells
por: Yan, Xiaodong, et al.
Publicado: (2020)

Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance
por: Fedorov, Oleg, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vt85mmn8nn1u05mkcrod19ddda